10.3 Medication Safety, Incident Analysis, and Quality Improvement

10.3 Medication Safety, Incident Analysis, and Quality Improvement

Exam Focus: The PEBC Pharmacist Evaluating Examination evaluates the candidate's understanding of systems-based medication safety, incident analysis, and error prevention. Candidates must master James Reason's Swiss Cheese Model, the Just Culture framework, Root Cause Analysis ($RCA$), Failure Mode and Effects Analysis ($FMEA$), ISMP Canada standards for high-alert medications and Tall Man lettering, the hierarchy of error-reduction strategies, and continuous quality improvement ($CQI$) reporting.

---

Taxonomy of Medication Safety

Understanding the precise distinctions between adverse events, adverse drug reactions, and medication errors is foundational to healthcare risk management.

+-------------------------------------------------------------------------+
|                   MEDICATION INCIDENT RELATIONSHIPS                     |
+-------------------------------------------------------------------------+
|  1. MEDICATION ERROR:                                                   |
|     Any PREVENTABLE event that may cause or lead to inappropriate       |
|     medication use or patient harm while in the control of the          |
|     healthcare professional, patient, or consumer.                      |
|                                                                         |
|  2. ADVERSE DRUG EVENT (ADE):                                           |
|     An injury or harm resulting from medical intervention related to a  |
|     drug. ADEs include harm from medication errors (preventable ADEs)   |
|     and harm from adverse drug reactions (non-preventable ADEs).        |
|                                                                         |
|  3. ADVERSE DRUG REACTION (ADR):                                        |
|     A noxious, unintended response to a drug occurring at normal doses  |
|     used for prophylaxis, diagnosis, or therapy (inherently non-        |
|     preventable under appropriate prescribing).                         |
|                                                                         |
|  4. NEAR MISS / CLOSE CALL:                                             |
|     An event, situation, or error that took place but was intercepted   |
|     and corrected before reaching the patient (e.g., pharmacist catches |
|     a 10-fold dosing error during prescription verification).           |
+-------------------------------------------------------------------------+

---

Systems-Based Safety versus the Person Approach

• Person Approach: Focuses on the individual at the "sharp end" (the practitioner administering or dispensing the drug). Blames errors on forgetfulness, inattention, carelessness, or moral failing. Relies on punitive measures ("blame and shame"), which drive error reporting underground and fail to resolve underlying vulnerabilities.
• Systems Approach: Recognizes that humans are inherently fallible and errors will occur. Focuses on the "blunt end" (the organizational structures, processes, technologies, and working environments). Aims to build resilient defense mechanisms, forcing functions, and safeguards that prevent errors from reaching the patient.

James Reason's Swiss Cheese Model

In James Reason's accident causation model, an organization's defense systems are represented as multiple slices of Swiss cheese lined up alongside one another. The holes in each slice represent individual system weaknesses:

• Latent Conditions: Systemic organizational defects (e.g., poor staffing ratios, underfunded software, poorly designed look-alike packaging, excessive noise/distractions, inadequate training).
• Active Failures: Direct slips, lapses, or mistakes committed by frontline practitioners at the bedside or dispensing counter.
• An adverse event occurs only when the holes in all defensive slices momentarily align, allowing a hazard trajectory to pass through unobstructed and cause patient harm.

+-------------------------------------------------------------------------+
|                    THE SWISS CHEESE ACCIDENT MODEL                      |
+-------------------------------------------------------------------------+
|   HAZARD ---> [Slice 1: CPOE Order Entry] (Hole: Confusing dropdown)    |
|                  |
|                  v
|               [Slice 2: Pharmacist Check] (Hole: Phone distraction)     |
|                  |
|                  v
|               [Slice 3: Automated Cabinet] (Hole: Override active)      |
|                  |
|                  v
|               [Slice 4: Bedside Barcoding] (Hole: Scanner uncharged)    |
|                  |
|                  v
|               PATIENT HARM (Catastrophic Overdose)                      |
+-------------------------------------------------------------------------+

---

The Just Culture Framework in Pharmacy

A Just Culture creates an atmosphere of trust where healthcare workers are encouraged and rewarded for reporting safety-related information, while maintaining a clear line between acceptable and unacceptable human behavior.

+-------------------------------------------------------------------------+
|                 DAVID MARX JUST CULTURE DECISION ALGORITHM              |
+-------------------------------------------------------------------------+
|  1. HUMAN ERROR (Inadvertent Slip, Lapse, or Honest Mistake):          |
|     - Practitioner inadvertently misreads a poorly printed label        |
|     - Management Action: CONSOLE the practitioner; evaluate and redesign|
|       system defenses, lighting, and packaging.                         |
|                                                                         |
|  2. AT-RISK BEHAVIOR (Behavioral Choice with Underestimated Risk):      |
|     - Practitioner creates a workaround (e.g., borrowing medications    |
|       from another patient's cassette, disabling nuisance alerts)       |
|       believing the shortcut is harmless or necessary for efficiency.   |
|     - Management Action: COACH the practitioner; remove organizational  |
|       incentives for shortcuts, and address workflow bottlenecks.       |
|                                                                         |
|  3. RECKLESS BEHAVIOR (Conscious Disregard of Substantial Risk):        |
|     - Practitioner intentionally bypasses mandatory independent double- |
|     check protocols while impaired or knowing harm is likely.           |
|     - Management Action: DISCIPLINARY and remedial regulatory action.   |
+-------------------------------------------------------------------------+

---

Incident Analysis: Retrospective and Prospective Frameworks

1. Root Cause Analysis (RCA) / Incident Analysis (Retrospective)

Root Cause Analysis (RCA) is a structured, multidisciplinary retrospective investigation conducted following a critical incident or sentinel event to identify underlying systemic latent failures rather than individual blame.

• Key Steps:
  1. Form a multidisciplinary team (pharmacists, nurses, physicians, quality leads, risk managers).
  2. Reconstruct the chronological event sequence through chart review, computer logs, and staff interviews.
  3. Identify contributing factors across all domains using the Canadian Incident Analysis Framework.
  4. Determine fundamental root causes (ask "Why?" iteratively).
  5. Formulate an actionable Quality Improvement plan with measurable outcome markers.
• The 5 Whys Technique: Iteratively questioning why an event happened to drill down past immediate symptoms to foundational systemic failures.
• Ishikawa (Fishbone) Cause-and-Effect Diagram: Categorizes contributing factors into five primary domains (the 5Ms/PEEP): People/Personnel, Processes/Methods, Equipment/Machines, Environment, and Management/Organization.

2. Failure Mode and Effects Analysis (FMEA / HFMEA) (Prospective)

Failure Mode and Effects Analysis (FMEA) is a proactive, prospective risk assessment tool used to evaluate a new process or clinical technology before implementation to identify vulnerabilities and prevent errors.

• Steps:
  1. Map out every individual step of the proposed process (e.g., robotic dispensing implementation).
  2. Brainstorm potential Failure Modes (what could go wrong at each step?).
  3. Determine the potential Failure Effects and causes.
  4. Assign numerical scores (scaled 1 to 10) for:
     • Severity ($S$): How severe is the clinical impact if the failure occurs?
     • Occurrence ($O$): How frequently is the failure likely to occur?
     • Detection ($D$): What is the likelihood that the failure will be detected before reaching the patient? (1 = almost certain detection; 10 = undetectable).
  5. Calculate the Risk Priority Number ($RPN$): $RPN = \text{Severity ($S$)} \times \text{Occurrence ($O$)} \times \text{Detection ($D$)}$ (RPN values range from 1 to 1,000; steps with the highest RPNs are prioritized for redesign).

---

High-Alert Medications and ISMP Canada Standards

The Institute for Safe Medication Practices Canada (ISMP Canada) defines high-alert medications as drugs that bear a heightened risk of causing significant patient harm when used in error.

The PINCH High-Alert Mnemonic

• P - Potassium and Concentrated Electrolytes: Concentrated Potassium Chloride ($KCl \ge 2\text{ mmol/mL}$), Sodium Chloride injection ($> 0.9%$), Potassium Phosphate. Mandatory Safeguard: Ban concentrated electrolyte ampoules/vials from patient care floor stock; dispense only as premixed, diluted IV bags from the pharmacy.
• I - Insulin: Subcutaneous and IV infusions. Rapid-acting vs long-acting analog mix-ups; U-500 concentration errors. Safeguard: Dedicated insulin syringes, independent double-checks, standardized protocols.
• N - Narcotics and Opioids: Hydromorphone, morphine, fentanyl, methadone, oxycodone. Safeguard: Hydromorphone is ~5 times more potent than IV morphine; color-coded packaging; locked automated dispensing cabinets.
• C - Chemotherapy / Cytotoxic Agents: Parenteral and oral antineoplastic agents (e.g., methotrexate daily vs weekly dosing errors; vincristine fatal intrathecal administration). Safeguard: Vincristine dispensed in minibags, NEVER in syringes; clear warning labels.
• H - Heparin and Anticoagulants: Unfractionated heparin, low-molecular-weight heparins (enoxaparin, dalteparin), direct oral anticoagulants, warfarin. Safeguard: Separate storage of high-dose heparin flushes ($10,000\text{ units/mL}$) from standard catheter flushes ($10\text{ to }100\text{ units/mL}$).

Look-Alike Sound-Alike (LASA) Medications & Tall Man Lettering

ISMP Canada and Health Canada recommend Tall Man Lettering (capitalizing distinctive letter strings) to distinguish easily confused drug name pairs.

Prohibited Error-Prone Abbreviations

---

Hierarchy of Error-Reduction Strategies

ISMP Canada ranks error-reduction strategies based on their leverage and human reliance.

+-------------------------------------------------------------------------+
|                HIERARCHY OF ERROR REDUCTION STRATEGIES                  |
+-------------------------------------------------------------------------+
|  HIGH-LEVERAGE (Most Effective - System-Focused):                       |
|  - Forcing Functions & Physical Constraints                             |
|    (e.g., ENFit enteral connectors incompatible with IV luer lines)     |
|  - Automation & Computerized Hard Stops                                 |
|    (e.g., Smart Infusion Pumps with Dose Error Reduction Systems [DERS])|
|                                                                         |
|  MEDIUM-LEVERAGE (Moderately Effective - Process-Focused):               |
|  - Standardization & Simplification (Preprinted order sets)             |
|  - Independent Double-Checks (Two practitioners verify independently)   |
|  - Visual Differentiation (Tall Man lettering, color-coded bins)        |
|                                                                         |
|  LOW-LEVERAGE (Least Effective - Human-Focused):                        |
|  - Auxiliary warning labels and pop-up soft alerts                      |
|  - Policies, standard operating procedures, and written rules           |
|  - Educational in-services, memos, and appeals to staff vigilance       |
+-------------------------------------------------------------------------+

Independent Double-Checks

• An independent double-check occurs when two healthcare practitioners separately and independently verify the prescriber's order, clinical calculation, product selection, and pump programming.
• Critical Rule: The second checker must never be primed by the first checker (e.g., the first checker must NOT say, "I drew up 5 mg of morphine, can you confirm this?"). Priming introduces confirmation bias and drastically reduces error detection rates.

---

Continuous Quality Improvement (CQI) in Canadian Pharmacies

Provincial pharmacy regulatory bodies mandate participation in standardized Continuous Quality Improvement (CQI) programs (e.g., AIMS in Ontario, SafetyNet in British Columbia, COMPASS in Saskatchewan).

• Mandatory Anonymous Reporting: Pharmacies must record all medication incidents and near misses into an accredited national repository (e.g., CPhIR - Community Pharmacy Incident Reporting via ISMP Canada; NSIR - National System for Incident Reporting via CIHI).
• Quarterly Safety Meetings: Pharmacy teams must conduct regular multidisciplinary reviews of incident trends and analyze root causes.
• Plan-Do-Study-Act (PDSA) Cycles: Rapid cycles of testing quality improvements in small-scale practice environments before implementing system-wide changes.